List of bibliographic references indexed by Viral Vaccines
Number of relevant bibliographic references: 16.
Ident. | Authors (with country if any) | Title |
---|
000070 (2020) |
Frédéric Iseni [France] ; Jean-Nicolas Tournier [France] | [A race against the clock: creation of SARS-Cov-2 in the laboratory, a month after its emergence!] |
000347 (2020) |
Carsten Weiss [Allemagne] ; Marie Carriere [France] ; Laura Fusco [Italie, Qatar] ; Ilaria Capua [États-Unis] ; Jose Angel Regla-Nava [États-Unis] ; Matteo Pasquali [États-Unis] ; James A. Scott [Canada] ; Flavia Vitale [États-Unis] ; Mehmet Altay Unal [Turquie] ; Cecilia Mattevi [Royaume-Uni] ; Davide Bedognetti [Qatar] ; Arben Merkoçi [Espagne] ; Ennio Tasciotti [États-Unis] ; Açelya Yilmazer [Turquie] ; Yury Gogotsi [États-Unis] ; Francesco Stellacci [Suisse] ; Lucia Gemma Delogu [Italie] | Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic. |
000456 (2020) |
Edouard Alphandéry [France, Suisse] | The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis. |
000562 (2020) |
Manish Sarkar [Inde] ; Soham Saha [France] | Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies. |
000609 (2020) |
Lucia Grenga [France] ; Fabrice Gallais [France] ; Olivier Pible [France] ; Jean-Charles Gaillard [France] ; Duarte Gouveia [France] ; Hélène Batina [France] ; Niza Bazaline [France] ; Sylvie Ruat [France] ; Karen Culotta [France] ; Guylaine Miotello [France] ; Stéphanie Debroas [France] ; Marie-Anne Roncato [France] ; Gérard Steinmetz [France] ; Charlotte Foissard [France] ; Anne Desplan [France] ; Béatrice Alpha-Bazin [France] ; Christine Almunia [France] ; Fabienne Gas [France] ; Laurent Bellanger [France] ; Jean Armengaud [France] | Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines. |
000662 (2020) |
Marc Baay [Belgique] ; Bruno Lina [France] ; Arnaud Fontanet [France] ; Arnaud Marchant [Belgique] ; Melanie Saville [Royaume-Uni] ; Philippe Sabot [Suisse] ; Philippe Duclos [Suisse] ; Joris Vandeputte [Suisse] ; Pieter Neels [Suisse] | SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. |
000670 (2020) |
Antoine Danchin [France, République populaire de Chine] ; Kenneth Timmis [Allemagne] | SARS-CoV-2 variants: Relevance for symptom granularity, epidemiology, immunity (herd, vaccines), virus origin and containment? |
000B87 (2020) |
Umit H. Kartoglu [Suisse] ; Kelly L. Moore [États-Unis] ; John S. Lloyd [France] | Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers. |
000D92 (2020) |
Ibrahim Yakoub-Agha [France] | Hydroxychloroquine in Covid-19: Does the end justify the means? |
001051 (2020) |
Lucy Van Dorp [Royaume-Uni] ; Mislav Acman [Royaume-Uni] ; Damien Richard [France] ; Liam P. Shaw [Royaume-Uni] ; Charlotte E. Ford [Royaume-Uni] ; Louise Ormond [Royaume-Uni] ; Christopher J. Owen [Royaume-Uni] ; Juanita Pang [Royaume-Uni] ; Cedric C S. Tan [Royaume-Uni] ; Florencia A T. Boshier [Royaume-Uni] ; Arturo Torres Ortiz [Royaume-Uni] ; François Balloux [Royaume-Uni] | Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. |
001175 (2020) |
Ramesh Kandimalla [Inde] ; Albin John [États-Unis] ; Chandrika Abburi [États-Unis] ; Jayalakshmi Vallamkondu [Inde] ; P Hemachandra Reddy [États-Unis] | Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics. |
001203 (2020) |
Roch Houot [États-Unis] ; Ronald Levy [États-Unis] ; Guillaume Cartron [France] ; Philippe Armand [États-Unis] | Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine? |
001414 (2020) |
Samir Jawhara [France] | Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19? |
001810 (2020) |
Tamim Alsuliman [France] ; Lugien Alasadi [Oman] ; Banan Alkharat [Oman] ; Micha Srour [France] ; Ali Alrstom [Syrie] | A review of potential treatments to date in COVID-19 patients according to the stage of the disease. |
001830 (2020) |
| A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. |
001877 (2020) |
Robyn Ralph [Canada] ; Jocelyne Lew [Canada] ; Tiansheng Zeng [République populaire de Chine] ; Magie Francis [Canada] ; Bei Xue [République populaire de Chine] ; Melissa Roux [Canada] ; Ali Toloue Ostadgavahi [Canada] ; Salvatore Rubino [Italie] ; Nicholas J. Dawe [Canada] ; Mohammed N. Al-Ahdal [Arabie saoudite] ; David J. Kelvin [République populaire de Chine] ; Christopher D. Richardson [Canada] ; Jason Kindrachuk [Canada] ; Darryl Falzarano [Canada] ; Alyson Anne Kelvin [Canada] | 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Viral Vaccines"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i \
-Sk "Viral Vaccines" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Mesh.i
|clé= Viral Vaccines
}}
| This area was generated with Dilib version V0.6.37. Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021 | |